Neuroscience 2026
Accelerate Your Pipeline with Cyagen's Models & CRO Expertise：From Target Validation to Proof-of-Concept
Featured Experts
Resources
Swags & Offers
Featured Experts
Dr. Jenny Shan (MD, PhD) brings decades of R&D experience from industry leaders like Regeneron, Moderna, J&J, EQRx, Apogee, and Curie.Bio.
Her expertise spans diverse modalities—antibodies, small molecules, ADCs, CAR-T, mRNA, siRNA, peptides, oligonucleotides, AAV, and gene editing—across oncology, immunology, cardiovascular, neuroscience, and ophthalmology.
As a strategic pipeline architect, Dr. Shan has advanced multiple programs from discovery to clinical development. She supported the IND and regulatory approvals for numerous biologics, contributing to blockbuster drugs such as Eylea, Dupixent, Carvykti, and Rybrevant.
Delaine is a scientist-turned business development leader with a strong background in metabolism, circadian biology, and cancer research. She completed a B.A. in Biology at the University of Puerto Rico before earning her Ph.D. in Biochemistry from the University of Pennsylvania. She then transitioned from academic research into a commercial role, supporting therapeutic innovation.
Her expertise spans diverse modalities—antibodies, small molecules, ADCs, CAR-T, mRNA, siRNA, peptides, oligonucleotides, AAV, and gene editing—across oncology, immunology, cardiovascular, neuroscience, and ophthalmology.
She now leverages her scientific training and strategic approach to connect researchers—from academic groups to global pharmaceutical teams—with solutions that accelerate discovery and advance innovation.
Daniel Cook is a Boston-based Business Development Manager at Cyagen Biosciences, covering the Northeast territory. He previously drove genomics sales at Novogene and holds an M.S. in Bioinformatics from Brandeis University and a B.A. in Biochemistry & Molecular Biology from Clark University.
Swags & Offers
